N
Nevena Secen
Researcher at University of Novi Sad
Publications - 16
Citations - 250
Nevena Secen is an academic researcher from University of Novi Sad. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 5, co-authored 14 publications receiving 122 citations.
Papers
More filters
Journal ArticleDOI
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study.
Byoung Chul Cho,Delvys Rodriguez Abreu,Maen A. Hussein,Manuel Cobo,Anjan Jayantilal Patel,Nevena Secen,Ki Hyeong Lee,Bartomeu Massuti,Sandrine Hiret,James Chih-Hsin Yang,Fabrice Barlesi,Dae Ho Lee,L. Arés,Robert W. Hsieh,Namrata Patil,P E Twomey,Xiaoying Yang,Raymond D. Meng,Melissa Lynne Johnson +18 more
TL;DR: Tiragolumab plus atezolizumab (anti-PD-L1) therapy was used as first-line treatment for non-small-cell lung cancer (NSCLC) as discussed by the authors .
Journal ArticleDOI
Pneumothorax: from definition to diagnosis and treatment
Paul Zarogoulidis,Ioannis Kioumis,Georgia Pitsiou,Konstantinos Porpodis,Sofia Lampaki,Antonis Papaiwannou,Nikolaos Katsikogiannis,Bojan Zaric,Perin Branislav,Nevena Secen,Georgios Dryllis,Nikolaos Machairiotis,Aggeliki Rapti,Konstantinos Zarogoulidis +13 more
TL;DR: In the current special issue the authors will present the definition, diagnosis and treatment of pneumothorax from different experts in the field, different countries and present different methods of treatment.
Journal ArticleDOI
Influence of dexamethasone on appetite and body weight in lung cancer patients
TL;DR: In this article, the influence of dexamethasone on appetite loss and weight loss in lung cancer patients treated with chemotherapy was investigated, and a statistically significant difference in appetite loss between two groups after the second chemotherapy cycle favoring group A. The most effective type of corticosteroids, dose and route of administration have not been established.
Journal ArticleDOI
Defense mechanisms of the respiratory system and aerosol production systems.
Paul Zarogoulidis,Paul Zarogoulidis,Kaid Darwiche,Lonny Yarmus,Dionysios Spyratos,Nevena Secen,Wolfgang Hohenforst-Schmidt,Nikolaos Katsikogiannis,Haidong Huang,Andreas Gschwendtner,Konstantinos Zarogoulidis +10 more
TL;DR: Current methods of aerosol production and distribution will be presented along with an overview of the respiratory defense mechanisms, and methods of Aerosol evaluation in conjunction with a future perspective of the potential developed aerosol therapies will be present.
Journal ArticleDOI
Clinical Risk Factors for Early Complications After High-Dose-Rate Endobronchial Brachytherapy in the Palliative Treatment of Lung Cancer
Bojan Zaric,Branislav Perin,Aleksandra Jovelic,Nensi Lalic,Nevena Secen,Ivan Kopitovic,Milan Antonic +6 more
TL;DR: The results indicate that closer monitoring of patients with identified risk factors is advisable, and should be performed both before and after treatment, to avoid complications.